Blog & News

Not quite – but we may at last have a drug that slows its progression.

It’s all over the news – and rightly so. The pharmaceutical company Eli Lilly have today announced that their dementia drug solanezumab could slow the rate at which Alzheimer’s progresses.

What you need to know:

  • it’s not a cure but it is the first drug ever to directly affect the progression of Alzheimer’s disease – no other treatment has ever been shown to do this

  • the initial trial ended unsuccessfully in 2012 but re-a...

Please reload

Join for free.

Download Quealth to your phone today.

Quealth on Android

Privacy policy       Terms of use


©2020 roadtohealth group ltd. Quealth is a brand under the roadtohealth group of companies. 

The 'Q' logo and 'Quealth – Healthier. Together.' are registered trademarks (EU 015926777 and EU 015923154) owned by roadtohealth group ltd.